INDV — Recent News Coverage
All news mentioning INDV in ESEN's AI-graded feed
News stories with INDV as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on INDV. See /coverage/INDV for the 30-day aggregate.
SEEKINGALPHA
·
2026-08-03
NEUTRAL
BULLISH
CORR0.42
Supernus, Indivior stock jumps after all-stock deal to merge
$SUPN
$INDV
◈ ESEN AI
SUPN and INDV announced an all-stock merger, triggering immediate positive price action in both equities. All-stock deals typically signal management confidence in valuation multiples while avoiding cash drain, though e…
MANILATIMES.NET
·
2026-08-03
HIGH
BULLISH
CORR0.72
Supernus Announces Second Quarter 2026 Financial Results
$SUPN
$INDV
◈ ESEN AI
Supernus Pharmaceuticals delivered a 32% revenue beat in Q2 2026, with core growth products surging 52% year-over-year to $175.7M. This acceleration reflects strong commercial execution across the CNS portfolio, particu…
MANILATIMES.NET
·
2026-08-03
NEUTRAL
BULLISH
CORR0.42
Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance
$INDV
◈ ESEN AI
Indivior delivered Q2 2026 results showing 14% year-over-year revenue growth to $343 million, signaling sustained commercial momentum in its core business segments. The company's decision to raise full-year guidance ref…
MANILATIMES.NET
·
2026-08-03
HIGH
BULLISH
CORR0.72
Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
$SUPN
$INDV
◈ ESEN AI
Supernus Pharmaceuticals (SUPN) and Indivior announced a merger creating a combined CNS biopharmaceutical entity with approximately $2.2 billion in annual revenues. This transaction represents a significant consolidatio…
GLOBALNEWSWIRE
·
2026-08-03
HIGH
BULLISH
CORR0.72
Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
$SUPN
$INDV
◈ ESEN AI
The all-stock merger between Supernus Pharmaceuticals (SUPN) and Indivior Pharmaceuticals (INDV) represents a significant consolidation event in the CNS biopharmaceutical sector. This combination creates a scaled divers…
RTTNEWS.COM
·
2026-06-29
LOW
BULLISH
CORR0.42
5 Biotech Stocks That Skyrocketed 105% To 235% — TWST, INDV, MIRM & More
$TWST
$INDV
$MIRM
$BDSX
$CADL
◈ ESEN AI
This article highlights a curated selection of biotech equities that have delivered substantial gains, ranging from 105% to 235%, suggesting strong recent performance in the health care sector. The headline-driven forma…
EXPLORE OTHER FILTERS